World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
62
Citations
22479
World Ranking
3092
National Ranking
1448

Stuart C. Ray publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Stuart C. Ray sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 181 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Stuart C. Ray D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Stuart C. Ray sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 62 D-Index — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Stuart C. Ray is affiliated with the Johns Hopkins University School of Medicine in the United States. The primary field of study for this scientist is Medicine, with a particular focus on Infectious Diseases, Epidemiology, Hepatology, Radiology, Nuclear Medicine and Imaging, and Immunology.

The main topics covered in their research include:

  • SARS-CoV-2 and COVID-19 Research
  • Hepatitis C virus research
  • COVID-19 Clinical Research Studies
  • Hepatitis B Virus Studies
  • Monoclonal and Polyclonal Antibodies Research
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 detection and testing

Stuart C. Ray's recent publications feature a range of studies primarily relating to COVID-19 and immune responses. Notable papers include:

  • "Durable SARS-CoV-2 B cell immunity after mild or severe disease" (2021, Journal of Clinical Investigation)
  • "Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2" (2020, Journal of Clinical Investigation)
  • "IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function" (2022, JCI Insight)
  • "IgM autoantibodies recognizing ACE2 are associated with severe COVID-19" (2020, bioRxiv (Cold Spring Harbor Laboratory))
  • "Genomic diversity of SARS-CoV-2 during early introduction into the Baltimore-Washington metropolitan area" (2021, JCI Insight)

Frequent publication venues for Stuart C. Ray include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • Journal of Clinical Investigation
  • JCI Insight
  • Immunity

The scientist has worked with several frequent co-authors, revealing a collaborative research network. These include:

  • Andrea L. Cox
  • Justin R. Bailey
  • Nicole Skinner
  • Clinton O. Ogega
  • Andrew Pekosz

Best Publications

  • Full-Length Human Immunodeficiency Virus Type 1 Genomes from Subtype C-Infected Seroconverters in India, with Evidence of Intersubtype Recombination

    Kavita S. Lole;Robert C. Bollinger;Ramesh S. Paranjape;Deepak Gadkari

  • Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection

    Robert Thimme;David Oldach;Kyong Mi Chang;Kyong Mi Chang;Carola Steiger

  • Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

    Kui Li;Eileen Foy;Josephine C. Ferreon;Mitsuyasu Nakamura

  • Protection against persistence of hepatitis C.

    Shruti H. Mehta;Andrea Cox;Donald R. Hoover;Xiao Hong Wang

  • Intermittent HIV-1 Viremia (Blips) and Drug Resistance in Patients Receiving HAART

    Richard E. Nettles;Tara L. Kieffer;Tara L. Kieffer;Patty Kwon;Daphne Monie

  • Genetic Epidemiology of Hepatitis C Virus throughout Egypt

    Stuart C. Ray;Ray R. Arthur;Anthony Carella;Jens Bukh

  • Acute hepatitis C

    Anurag Maheshwari;Stuart Ray;Paul J Thuluvath

  • Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4+ T Cells

    Justin R. Bailey;Ahmad R. Sedaghat;Tara Kieffer;Timothy Brennan

  • Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity against Persistent Reinfection

    William O. Osburn;Brian E. Fisher;Kimberly A. Dowd;Giselle Urban

  • Cellular immune selection with hepatitis C virus persistence in humans

    Andrea L. Cox;Timothy Mosbruger;Qing Mao;Zhi Liu

  • Human Immunodeficiency Virus-Related Microbial Translocation and Progression of Hepatitis C

    Ashwin Balagopal;Frances H. Philp;Jacquie Astemborski;Timothy M. Block

  • Prospective Evaluation of Community‐Acquired Acute‐Phase Hepatitis C Virus Infection

    Andrea L. Cox;Dale M. Netski;Timothy Mosbruger;Susan G. Sherman

  • Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C.

    Andrea L. Cox;Timothy Mosbruger;Georg M. Lauer;Drew Pardoll

  • Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses.

    William O. Osburn;Anna E. Snider;Brittany L. Wells;Rachel Latanich

  • HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of <50 Copies/mL Receiving Combination Therapy

    Monika Hermankova;Stuart C. Ray;Christian Ruff;Monique Powell-Davis

  • Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus.

    Kimberly A. Dowd;Dale M. Netski;Xiao–Hong Wang;Andrea L. Cox

  • Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy

    Stuart C. Ray;Yu Ming Wang;Oliver Laeyendecker;John R. Ticehurst;John R. Ticehurst

  • Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads.

    Tara L. Kieffer;Mariel M. Finucane;Richard E. Nettles;Thomas C. Quinn;Thomas C. Quinn

  • A stable latent reservoir for HIV-1 in resting CD4+ T lymphocytes in infected children

    Deborah Persaud;Theodore Pierson;Christian Ruff;Diana Finzi

  • G→A Hypermutation in Protease and Reverse Transcriptase Regions of Human Immunodeficiency Virus Type 1 Residing in Resting CD4+ T Cells In Vivo

    Tara L. Kieffer;Patty Kwon;Richard E. Nettles;Yefei Han

  • Cross-Genotype Immunity to Hepatitis C Virus

    Robert E. Lanford;Bernadette Guerra;Deborah Chavez;Catherine Bigger

Frequent Co-Authors

David L. Thomas
David L. Thomas Johns Hopkins University
Andrea L. Cox
Andrea L. Cox Johns Hopkins University School of Medicine
Thomas C. Quinn
Thomas C. Quinn Johns Hopkins University
Oliver Laeyendecker
Oliver Laeyendecker Johns Hopkins University
Robert F. Siliciano
Robert F. Siliciano Johns Hopkins University School of Medicine
Shruti H. Mehta
Shruti H. Mehta Johns Hopkins University
Joel N. Blankson
Joel N. Blankson Johns Hopkins University School of Medicine
Jacquie Astemborski
Jacquie Astemborski Johns Hopkins University
David Vlahov
David Vlahov Yale University
James E. Crowe
James E. Crowe Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those exploring Immunology in the USA, diversifying your education with related healthcare degrees can open numerous career opportunities. Nursing programs often complement an immunology background, especially for roles in clinical research or patient care. Many students consider accelerated FNP programs, which provide a fast track to becoming a Family Nurse Practitioner, allowing professionals to work closely with immunology-related cases.

If you’re coming from a non-nursing background, online nursing programs for non nurses offer a convenient way to enter the nursing field. These programs help bridge the gap between immunology research and practical healthcare delivery.

Additionally, if you aim to complete your Bachelor of Science in Nursing more quickly, exploring accelerated nursing programs can be a smart choice. These courses typically have streamlined admission processes and intensive curricula to get graduates into the workforce faster.

For those just starting out or looking for entry-level roles, considering LPN programs with easiest admission requirements can provide practical nursing skills with relatively accessible enrollment. This foundation can support further immunology-related career growth over time.

Best Scientists Citing Stuart C. Ray

Trending Scientists

Recently Published Articles